PWS
TMO icon

Peloton Wealth Strategists’s Thermo Fisher Scientific TMO Stock Holding History

Peloton Wealth Strategists’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.5M Sell
9,161
-2,895
-24% -$1.57M 1.82% 16
2025
Q4 		$6.99M Sell
12,056
-155
-1% -$87.7K 2.71% 11
2025
Q3 		$5.92M Sell
12,211
-275
-2% -$128K 2.33% 13
2025
Q2 		$5.06M Sell
12,486
-35
-0.3% -$14.6K 2.03% 14
2025
Q1 		$6.23M Sell
12,521
-375
-3% -$203K 2.6% 10
2024
Q4 		$6.71M Sell
12,896
-100
-0.8% -$55K 2.71% 12
2024
Q3 		$8.04M Sell
12,996
-401
-3% -$237K 3.2% 2
2024
Q2 		$7.41M Sell
13,397
-200
-1% -$115K 3.05% 5
2024
Q1 		$7.9M Sell
13,597
-324
-2% -$182K 3.21% 2
2023
Q4 		$7.39M Sell
13,921
-220
-2% -$106K 3.2% 2
2023
Q3 		$7.16M Sell
14,141
-500
-3% -$266K 3.3% 2
2023
Q2 		$7.64M Sell
14,641
-344
-2% -$186K 3.38% 2
2023
Q1 		$8.64M Sell
14,985
-215
-1% -$121K 3.95% 1
2022
Q4 		$8.37M Sell
15,200
-110
-0.7% -$58.3K 4.03% 1
2022
Q3 		$7.76M Buy
15,310
+21
+0.1% +$11.8K 4.04% 1
2022
Q2 		$8.31M Sell
15,289
-835
-5% -$460K 4.05% 1
2022
Q1 		$9.58M Sell
16,124
-195
-1% -$112K 4% 1
2021
Q4 		$10.9M Sell
16,319
-130
-0.8% -$81.2K 4.36% 1
2021
Q3 		$9.4M Buy
16,449
+330
+2% +$181K 3.85% 1
2021
Q2 		$8.13M Buy
16,119
+840
+5% +$396K 3.36% 3
2021
Q1 		$6.97M Buy
15,279
+1,515
+11% +$723K 3.27% 3
2020
Q4 		$6.41M Sell
13,764
-315
-2% -$148K 3.18% 2
2020
Q3 		$6.22M Buy
14,079
+144
+1% +$59.5K 3.48% 3
2020
Q2 		$5.05M Buy
13,935
+1,830
+15% +$613K 3.18% 3
2020
Q1 		$3.43M Buy
12,105
+1,075
+10% +$339K 2.8% 5
2019
Q4 		$3.58M Buy
11,030
+300
+3% +$91K 2.17% 13
2019
Q3 		$3.13M Buy
10,730
+70
+0.7% +$20K 2% 16
2019
Q2 		$3.13M Buy
10,660
+160
+2% +$44.1K 2.1% 16
2019
Q1 		$2.87M Sell
10,500
-400
-4% -$99.5K 1.99% 19
2018
Q4 		$2.44M Sell
10,900
-227
-2% -$53.3K 1.98% 17
2018
Q3 		$2.72M Sell
11,127
-100
-0.9% -$23K 1.87% 24
2018
Q2 		$2.33M Hold
11,227
– – 1.68% 31
2018
Q1 		$2.32M Hold
11,227
– – 1.75% 29
2017
Q4 		$2.13M Hold
11,227
– – 1.58% 31
2017
Q3 		$2.12M Sell
11,227
-710
-6% -$129K 1.64% 28
2017
Q2 		$2.08M Sell
11,937
-400
-3% -$67.2K 1.61% 26
2017
Q1 		$1.9M Sell
12,337
-700
-5% -$107K 1.56% 27
2016
Q4 		$1.84M Sell
13,037
-700
-5% -$103K 1.5% 25
2016
Q3 		$2.19M Buy
+13,737
New +$2.12M 1.82% 22
2016
Q1 		$2.38M Sell
16,837
-100
-0.6% -$13.4K 2.02% 18
2015
Q4 		$2.4M Sell
16,937
-263
-2% -$35.1K 2.07% 15
2015
Q3 		$2.1M Sell
17,200
-1,000
-5% -$130K 1.84% 16
2015
Q2 		$2.36M Sell
18,200
-300
-2% -$39.1K 1.88% 17
2015
Q1 		$2.48M Sell
18,500
-100
-0.5% -$12.9K 1.93% 14
2014
Q4 		$2.33M Sell
18,600
-400
-2% -$48.6K 1.77% 22
2014
Q3 		$2.31M Buy
19,000
+5,263
+38% +$640K 1.82% 20
2014
Q2 		$2.03M Sell
13,737
-5,563
-29% -$655K 1.79% 23
2014
Q1 		$2.32M Sell
19,300
-7,300
-27% -$868K 1.91% 17
2013
Q4 		$2.96M Sell
26,600
-2,100
-7% -$209K 2.4% 6
2013
Q3 		$2.65M Hold
28,700
– – 2.22% 9
2013
Q2 		$2.43M Buy
+28,700
New +$2.39M 2.19% 13

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Peloton Wealth Strategists's TMO Position: Q1 2026 in Review

Peloton Wealth Strategists reduced its Thermo Fisher Scientific (TMO) stake by 24% in Q1 2026, selling an estimated $1.57M and leaving 9,161 shares worth $4.5M. The position accounts for 1.82% of the portfolio, ranked #16.

Peloton Wealth Strategists first reported a position in TMO in Q2 2013 and has held it in 51 quarters since. The position peaked at $10.9M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Peloton Wealth Strategists held 9,161 shares of Thermo Fisher Scientific worth $4.5M as of Q1 2026.
  • Peloton Wealth Strategists sold 2,895 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.57M.
  • Thermo Fisher Scientific made up 1.82% of Peloton Wealth Strategists's portfolio in Q1 2026, its #16 holding.
  • Peloton Wealth Strategists first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 51 quarters since.
  • Peloton Wealth Strategists's Thermo Fisher Scientific position peaked at $10.9M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Peloton Wealth Strategists's 13F filing for Q1 2026, filed 14 May 2026.